Coronavirus whistleblower Rick Bright’s complaint shows high likelihood of ‘wrongdoing,’ watchdog says

Rick Bright has claimed he was removed as director of the Biomedical Advanced Research and Development Authority after resisting efforts to increase access to an anti-malarial drug promoted by President Trump as a treatment for Covid-19.